Stay updated on Surufatinib in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Surufatinib in Advanced Solid Tumors Clinical Trial page
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site-wide notice about government funding operating status was removed from the page, so the alert is no longer displayed on the study details screen.SummaryDifference0.3%

- Check42 days agoChange DetectedMinor formatting and layout adjustments observed between the two screenshots; there are no changes to core trial information such as the title, eligibility criteria, locations, or primary endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check78 days agoChange DetectedThe page now declares Revision: v3.1.0 instead of v3.0.2, indicating a new release/version update.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page revision updates from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

Stay in the know with updates to Surufatinib in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib in Advanced Solid Tumors Clinical Trial page.